Veradermics, Incorporated (NYSE:MANE – Get Free Report) has earned an average rating of “Moderate Buy” from the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $114.20.
MANE has been the subject of a number of recent analyst reports. Lifesci Capital initiated coverage on shares of Veradermics in a report on Tuesday. They issued an “outperform” rating and a $135.00 target price for the company. Leerink Partners boosted their price objective on shares of Veradermics from $75.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Jefferies Financial Group began coverage on shares of Veradermics in a research note on Monday, March 2nd. They set a “buy” rating and a $75.00 price objective for the company. Needham & Company LLC began coverage on shares of Veradermics in a research note on Tuesday, June 2nd. They set a “buy” rating and a $136.00 price objective for the company. Finally, Wall Street Zen upgraded shares of Veradermics from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th.
View Our Latest Stock Report on Veradermics
Veradermics Stock Down 0.1%
Veradermics (NYSE:MANE – Get Free Report) last released its earnings results on Tuesday, May 12th. The company reported ($1.32) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.76).
Veradermics Company Profile
MANE is a global manufacturer and supplier of flavors, fragrances and ingredients for the food, beverage, personal care, household and fine fragrance markets. Headquartered in France, the company develops and produces aromatic solutions that are used by consumer goods companies, food processors, perfumers and formulators seeking sensory impact, taste modulation and olfactory character for their products.
The company’s product portfolio includes savory and sweet flavor systems, beverage concentrates, natural extracts, essential oils, fragrance compounds, cosmetic ingredients and specialty functional solutions such as taste enhancers and odor masking agents.
Read More
- Five stocks we like better than Veradermics
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Veradermics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradermics and related companies with MarketBeat.com's FREE daily email newsletter.
